Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma

Journal of Urology

Volumn 160, Issue 5, 1998, Pages 1914-1918

  Kugler, A ^a,b   Hemmerlein, B ^a   Thelen, P ^a   Kallerhoff, M ^a   Radzun, H J ^a   Ringert, R H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Matrix metalloproteinases; Renal cell carcinoma; Tissue inhibitors of metalloproteinases; Tumor progression

Indexed keywords

METALLOPROTEINASE INHIBITOR;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER STAGING; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0345109257     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62443-1     Document Type: Article

References (15)

1. Young, T. N., Rodriguez, G. C., Reinhart, A. R., Bast Jr., R. C., Pizzo, S. V. and Stack, M. S.: Characterization of gelatinases linked to extracellular matrix invasion in ovarian adeno carcinoma: purification of matrix metalloproteinase 2. Gynecol. Oncol., 62: 89, 1996.
2. Ray, J. M. and Stetler-Stevenson, W. G.: The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J., 7: 2062, 1994.
3. Miyajima, Y., Nakano, R. and Morimatsu, M.: Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann. Otol. Rhinol. Laryngol., 104: 678, 1995.
4. Hamdy, F. C., Faldon, E. J., Cottam, D., Lawry, J., Thurrell, W., Silcocks, P. B., Anderson, J. B., Williams, J. L. and Rees, R. C.: Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign hyperplasia. Br. J. Cancer, 69: 177, 1944.
5. Mori, M., Mimori, K., Shiraishi, T., Fujie, T., Baba, K., Kusumoto, H., Haraguchi, M., Ueo, H. and Akiyoshi, T.: Analysis of MT1-MMP and MMP 2 expression in human gastric cancers. Int. J. Cancer, 74: 316, 1997.
6. Nuovo, G. J., MacConnell, P. B., Simsir, A., Valea, F. and French, D. L.: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res., 55: 267, 1995.
7. Vaisanen, A., Tuominen, H., Kallioinen, M. and Turpeenniemi-Hujanen, T.: Matrix metalloproteinase 2 (72-kDa collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J. Pathol., 180: 283, 1996.
8. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinium thioacetate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
9. Zucker, S., Lysik, R. M., Malik, M., Bauer, B. A., Caamano, J., Klein-Szanto and A. J. P.: Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis. Int. J. Cancer, 52: 366, 1992.
10. Liotta, L. A.: Tumor invasion and metastasis. Role of extracellular matrix. Cancer Res., 46: 1, 1986.
11. Kusukawa, J., Sasaguri, Y., Shima, I., Kameyama, T. and Morimatsu, M.: Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathological study. Am. J. Clin. Pathol., 99: 18, 1993.
12. Shima, I., Sasaguri, Y., Kusukawa, J., Nakano, R., Yamana, H., Fujita, H., Kakegawa, T. and Morimatsu, M.: Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br. J. Cancer, 67: 712, 1993.
13. Gohji, K., Fujimoto, N., Komiyama, T., Fujii, A., Ohkawa, J., Kamidono, S. and Nikajima, M.: Evaluation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurence in patients with urothelial carcinoma. Cancer, 78: 2379, 1996.
14. Liabakk, N-B., Talbot, I., Smith, R. A., Wilkinson, K. and Balkwill, F.: Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res., 56: 190, 1996.
15. Lindsay, C. K., Thorgeirsson, U. P., Tsuda, H. and Hirohashi, S.: Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer. Hum. Pathol., 28: 359, 1997.